89 related articles for article (PubMed ID: 20305310)
1. Medical interventions for addictions in the primary care setting.
Bruce RD
Top HIV Med; 2010; 18(1):8-12. PubMed ID: 20305310
[TBL] [Abstract][Full Text] [Related]
2. Substance use of disorders in HIV-infected patients: impact and new treatment strategies.
Fiellin DA
Top HIV Med; 2004; 12(3):77-82. PubMed ID: 15310938
[TBL] [Abstract][Full Text] [Related]
3. Prioritizing primary care in HIV: comorbidity, toxicity, and demography.
Justice AC
Top HIV Med; 2006 Dec-2007 Jan; 14(5):159-63. PubMed ID: 17237557
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.
Sullivan LE; Fiellin DA
Clin Infect Dis; 2005 Sep; 41(6):891-6. PubMed ID: 16107991
[TBL] [Abstract][Full Text] [Related]
5. Initial strategies for integrating buprenorphine into HIV care settings in the United States.
Sullivan LE; Bruce RD; Haltiwanger D; Lucas GM; Eldred L; Finkelstein R; Fiellin DA
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S191-6. PubMed ID: 17109306
[TBL] [Abstract][Full Text] [Related]
6. Substance abuse and HIV infection.
Francis H
Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
[TBL] [Abstract][Full Text] [Related]
7. End-stage liver disease in HIV disease.
Peters MG
Top HIV Med; 2009; 17(4):124-8. PubMed ID: 19890184
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and treatment of lipodystrophy: what clinicians need to know.
Sattler FR
Top HIV Med; 2008; 16(4):127-33. PubMed ID: 18838747
[TBL] [Abstract][Full Text] [Related]
9. How some HIV clinics handle substance abuse.
Clements A; Gerse M; Mabry SH
AIDS Alert; 2001 Aug; 16(8):95-7. PubMed ID: 11547704
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
11. Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care.
Schackman BR; Merrill JO; McCarty D; Levi J; Lubinski C
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S247-53. PubMed ID: 17109311
[TBL] [Abstract][Full Text] [Related]
12. HIV testing: rationale for changing recommendations.
Janssen RS
Top HIV Med; 2007; 15(1):6-10. PubMed ID: 17406078
[TBL] [Abstract][Full Text] [Related]
13. Triple diagnosis: dual diagnosis and HIV disease, Part 1.
Douaihy AB; Jou RJ; Gorske T; Salloum IM
AIDS Read; 2003 Jul; 13(7):331-2, 339-41. PubMed ID: 12889451
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy: new drugs, formulations, ideas, and strategies.
Eron JJ
Top HIV Med; 2009 Dec; 17(5):146-50. PubMed ID: 20068261
[TBL] [Abstract][Full Text] [Related]
15. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
[TBL] [Abstract][Full Text] [Related]
16. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island.
Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L
Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657
[No Abstract] [Full Text] [Related]
17. [Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine].
Haro G; Cervera G; Martínez-Raga J; Pérez-Gálvez B; Fernández-Garcés M; Sanjuan J
Actas Esp Psiquiatr; 2003; 31(4):205-19. PubMed ID: 12838444
[TBL] [Abstract][Full Text] [Related]
18. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.
Cunningham CO; Sohler NL; McCoy K; Kunins HV
Fam Med; 2006 May; 38(5):336-40. PubMed ID: 16673195
[TBL] [Abstract][Full Text] [Related]
19. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
Turner BJ; Laine C; Lin YT; Lynch K
Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
[TBL] [Abstract][Full Text] [Related]
20. Medications development: successes and challenges.
Vocci F; Ling W
Pharmacol Ther; 2005 Oct; 108(1):94-108. PubMed ID: 16083966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
